81.74

1.62% 1.30

After Hours: 81.00 -0.74 -0.91%

Lantheus Holdings Inc (LNTH)

Overview News Price History Option Chain Financials Why LNTH Down? Discussions Forecast

Lantheus Holdings Inc stock is traded at $81.74, with a volume of 1.56M. It is up +1.62% in the last 24 hours and down -18.39% over the past month. Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Previous Close:

$80.44

Open:

$80.44

24h Volume:

1.56M

Relative Volume:

1.54

Market Cap:

$7.46B

Revenue:

$1.50B

Net Income/Loss:

$427.61M

P/E Ratio:

13.60

EPS:

6.01

Net Cash Flow:

$423.98M

1W Performance:

-24.83%

1M Performance:

-18.39%

6M Performance:

-6.58%

1Y Performance:

+7.69%

1-Day Range:

$79.55

$82.21

1-Week Range:

$78.92

$108.91

52-Week Range:

$75.00

$126.89

Lantheus Holdings Inc Stock (LNTH) Company Profile

Name

Lantheus Holdings Inc

Sector

Healthcare (1153)

Industry

Drug Manufacturers - Specialty & Generic (1)

Phone

978 671-8001

Address

331 TREBLE COVE ROAD, NORTH BILLERICA, MA

Employee

808

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

LNTH's Discussions on Twitter

Compare LNTH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LNTH Lantheus Holdings Inc	81.74	7.46B	1.50B	427.61M	423.98M	6.01
ZTS Zoetis Inc	159.27	70.23B	9.29B	2.52B	2.28B	5.57
HLN Haleon Plc Adr	10.74	48.23B	14.35B	1.85B	0	0.4023
TAK Takeda Pharmaceutical Co Adr	14.36	48.22B	30.08B	710.16M	4.45B	0.2182
TEVA Teva Pharmaceutical Industries Ltd Adr	16.93	18.57B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	301.42	13.29B	2.76B	1.11B	898.10M	22.77

Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-18-24	Initiated	Goldman	Buy
Sep-03-24	Initiated	Redburn Atlantic	Buy
Jul-10-24	Reiterated	JMP Securities	Mkt Outperform
Dec-18-23	Downgrade	William Blair	Outperform → Mkt Perform
Dec-04-23	Initiated	TD Cowen	Outperform
Sep-29-23	Initiated	William Blair	Outperform
Mar-08-23	Initiated	JMP Securities	Mkt Outperform
Nov-30-22	Initiated	SVB Leerink	Outperform
Oct-13-22	Initiated	Mizuho	Buy
May-09-22	Initiated	B. Riley Securities	Buy
Apr-13-22	Initiated	Truist	Buy
Feb-01-21	Initiated	SVB Leerink	Outperform
Jun-29-20	Resumed	Jefferies	Buy
Aug-16-19	Upgrade	CJS Securities	Market Perform → Market Outperform
Nov-02-17	Upgrade	Wells Fargo	Market Perform → Outperform
Nov-08-16	Reiterated	RBC Capital Mkts	Outperform
Sep-23-16	Resumed	Credit Suisse	Neutral
Feb-24-16	Reiterated	RBC Capital Mkts	Outperform
Dec-11-15	Downgrade	Credit Suisse	Outperform → Neutral
Sep-30-15	Downgrade	Wells Fargo	Outperform → Market Perform
Jul-20-15	Initiated	Credit Suisse	Outperform
Jul-20-15	Initiated	Jefferies	Buy
Jul-20-15	Initiated	RBC Capital Mkts	Outperform
Jul-20-15	Initiated	Robert W. Baird	Outperform
Jul-20-15	Initiated	Wells Fargo	Outperform

View All

Lantheus Holdings Inc Stock (LNTH) Latest News

03:43 AM

Lantheus Holdings stock drops on lowered full year outlook - MSN

03:43 AM

May 09, 2025

LNTH Q1 Earnings Call: Lantheus Lowers Outlook Amid Product Shifts and Divestitures - Yahoo Finance

May 09, 2025

Shareholder Rights Advocates at Levi & Korsinsky Investigate Lantheus Holdings, Inc. (LNTH) Regarding Possible Securities Fraud Violations - ACCESS Newswire

May 09, 2025

Lantheus price target lowered to $120 from $134 at JonesResearch - Yahoo Finance

May 09, 2025

Lantheus Holdings, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - Yahoo Finance

May 09, 2025

Truist cuts Lantheus stock price target to $117, maintains Buy By Investing.com - Investing.com South Africa

May 09, 2025

Lantheus announces pivotal trial win for Alzheimer’s imaging agent - MSN

May 09, 2025

May 08, 2025

LNTH: Sale of SPECT Tilts Growth to Novel Radiopharmaceuticals - Research Tree

May 08, 2025

Lantheus Holdings Inc earnings missed by $0.11, revenue fell short of estimates - Investing.com Nigeria

May 08, 2025

Lantheus Holdings, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsLNTH - marketscreener.com

May 08, 2025

Truist cuts Lantheus stock price target to $117, maintains Buy - Investing.com Australia

May 08, 2025

Lantheus projects $1.55B-$1.585B revenue for 2025 amid acquisitions and market growth - MSN

May 08, 2025

Lantheus (LNTH) Faces Challenges but Holds Long-Term Promise | LNTH Stock News - GuruFocus

May 08, 2025

LNTH: Truist Securities Lowers Price Target While Maintaining Buy Rating | LNTH Stock News - GuruFocus

May 08, 2025

Lantheus Holdings, Inc. (NASDAQ:LNTH) Q1 2025 Earnings Call Transcript - Insider Monkey

May 08, 2025

Lantheus Holdings First Quarter 2025 Earnings: Misses Expectations - simplywall.st

May 08, 2025

Petri Dish: Cancer biotech cuts staff; Lantheus sells business unit - The Business Journals

May 08, 2025

Why Lantheus Holdings, Inc. (LNTH) Nosedived on Wednesday - Insider Monkey

May 08, 2025

Why These 10 Firms Nosedived Today - Insider Monkey

May 08, 2025